Citations

Showing 10 of 108152 citations.

New and Emerging Treatments for the Acute and Preventive Therapy of Migraine and Other Headaches
Schwedt, Todd J.

Mayo Clinic

Headache: The Journal of Head and Face Pain | July 10, 2019 | Volume: 59 | Issue: S2 | Pages: 1-2

10.1111/head.13584 | PMID 31291019 Get It

A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
Galanis, Evanthia , Anderson, S. Keith , Twohy, Erin , Carrero, Xiomara W., Dixon, Jesse G. , Tran, David , Jeyapalan, Suriya, Anderson, Daniel M. , Feathers, Ryan W. , Buckner, Jan C. , Anastasiadis, Panos Z. , Schiff, David , Tran, David D. , Twohy, Erin L, Galanis, Evanthia , Kaufmann, Timothy J. , Giannini, Caterina , Dixon, Jesse G

Mayo Clinic

Cancer | July 10, 2019 | Volume: 125 | Issue: 21 | Pages: 3790-3800

10.1002/cncr.32340 | PMID 31290996 Get It

BackgroundSrc signaling is markedly upregulated in patients with invasive glioblastoma (GBM) after the administration of bevacizumab. The Src family kinase inhibitor dasatinib has been found to effectively block bevacizumab‐induced glioma invasion in preclinical models, which led to the hypothesis that combining bevacizumab with dasatinib could increase bevacizumab efficacy in patients with recurrent GBM.MethodsAfter the completion of the phase 1 component, the phase 2 trial (ClinicalTrials.gov identifier NCT00892177) randomized patients with recurrent GBM 2:1 to receive 100 mg of oral dasatinib twice daily (arm A) or placebo (arm B) on days 1 to 14 of each 14‐day cycle combined with 10 mg/kg of intravenous bevacizumab on day 1 of each 14‐day cycle. The primary endpoint was 6‐month progression‐free survival (PFS6).ResultsIn the 121 evaluable patients, the PFS6 rate was numerically, but not statistically, higher in arm A versus arm B (28.9% [95% CI, 19.5%‐40.0%] vs 18.4% [95% CI, 7.7%‐34.4%]; P = .22). Similarly, there was no significant difference in the median overall survival noted between the treatment arms (7.3 months and 7.7 months, respectively; P = .93). The objective response rate was 15.7% in arm A and 26.3% in arm B (P = .52), but with a significantly longer duration in patients treated on arm A (16.3 months vs 2 months). The incidence of grade ≥3 toxicity was comparable between treatment arms, with hematologic toxicities occurring more frequently in arm A versus arm B (15.7% vs 7.9%) (adverse events were assessed as per the National Cancer Institute Common Terminology Criteria for Adverse Events [version 4.0]). Correlative tissue analysis demonstrated an association between pSRC/LYN signaling in patient tumors and outcome.ConclusionsDespite upregulation of Src signaling in patients with GBM, the combination of bevacizumab with dasatinib did not appear to significantly improve the outcomes of patients with recurrent GBM compared with bevacizumab alone.
Modelling the relationships between haemoglobin oxygen affinity and the oxygen cascade in humans
Shepherd, John R. A. , Dominelli, Paolo B. , Roy, Tuhin K. , Secomb, Timothy W. , Hoyer, James D., Oliveira, Jennifer L. , Herrick, Jennifer L. , Roy, Tuhin K , Secomb, Timothy W , Joyner, Michael J.

Mayo Clinic

The Journal of Physiology | July 10, 2019 | Volume: 597 | Issue: 16 | Pages: 4193-4202

10.1113/jp277591 | PMID 31290158 Get It

Key points Haemoglobin affinity is an integral concept in exercise physiology that impacts oxygen uptake, delivery and consumption. How chronic alterations in haemoglobin affinity impact physiology is unknown. Using human haemoglobin variants, we demonstrate that the affinity of haemoglobin for oxygen is highly correlated with haemoglobin concentration. Using the Fick equation, we model how altered haemoglobin affinity and the associated haemoglobin concentration influences oxygen consumption at rest and during exercise via alterations in cardiac output and mixed‐venous . The combination of low oxygen affinity haemoglobin and reduced haemoglobin concentration seen in vivo may be unable to support oxygen uptake during moderate or heavy exercise. AbstractThe physiological implications, with regard to exercise, of altered haemoglobin affinity for oxygen are not fully understood. Data from the Mayo Clinic Laboratories database of rare human haemoglobin variants reveal a strong inverse correlation (r = −0.82) between blood haemoglobin concentration and P50, an index of oxygen affinity [Hb = −0.3135(P50) + 23.636]. In the present study, observed P50 values for high, normal and low oxygen‐affinity haemoglobin variants (13, 26 and 39 mmHg) and corresponding haemoglobin concentrations (19.5, 15.5 and 11.4 g dL−1 respectively) are used to model oxygen consumption as a fraction of delivery at rest ( = 0.25 L min−1, cardiac output = 5.70 L min−1) and during exercise ( = 2.75 L min−1, cardiac output = 18.9 l min−1). With high‐affinity haemoglobin, the model shows that normal levels of oxygen consumption can be achieved at rest and during exercise at the assumed cardiac output levels, with reduced oxygen extraction both at rest (16.8% high affinity vs. 21.7% normal) and during exercise (55.8% high affinity vs. 72.2% normal). With low‐affinity haemoglobin, which predicts low haemoglobin concentration, oxygen consumption at rest can be sustained with the assumed cardiac output, with increased oxygen extraction (31.1% low affinity vs. 21.7% normal). However, exercise at 2.75 l min−1 cannot be achieved with the assumed cardiac output, even with 100% oxygen extraction. In conclusion, the model indicates chronic alterations in P50 associate directly with Hb concentration, highlighting that human Hb variants can serve as ‘experiments of nature’ to address fundamental hypotheses on oxygen transport and exercise.
Informant-based hearing difficulties and the risk for mild cognitive impairment and dementia
Vassilaki, Maria , Aakre, Jeremiah A. , Kremers, Walter K. , Geda, Yonas E. , Alfakir, Razan , Undavalli, Chaitanya, Roberts, Rosebud O., Petersen, Ronald C. , Al Fakir, Razan, Geda, Yonas E , Alfakir, Razan , Kremers, Walter K , Knopman, David S. , Mielke, Michelle M. , Machulda, Mary M.

Mayo Clinic

Age and Ageing | July 10, 2019 | Volume: 48 | Issue: 6 | Pages: 888-894

10.1093/ageing/afz099 | PMID 31437275 Get It

AbstractBackground: hearing loss has been associated with mild cognitive impairment (MCI) and dementia. Studies have not assessed whether hearing difficulties (HD) that interfere with daily activities as reported by partners can be a marker for increased risk for cognitive decline and impairment.Objective: to assess the cross-sectional and longitudinal associations between informant-based HD, which interfere with daily activities and the risk for MCI and dementia.Methods: the study included 4812 participants without dementia, enrolled in the Mayo Clinic Study of Aging (mean age (SD) 73.7 (9.6) years) with cognitive evaluation and informant-based report on participant’s HD that interfere significantly with daily activities at baseline and for every 15 months. Cox proportional hazards models (utilising time-dependent HD status and age as the time scale) were used to examine HD and the risk for MCI or dementia, and mixed-effects models (allowing for random subject-specific intercepts and slopes) were used to examine the relationship between HD and cognitive decline.Results: about, 981 participants had HD and 612 (12.7%) had prevalent MCI at baseline; 759 participants developed incident MCI and 273 developed incident dementia. In cognitively unimpaired participants at baseline, those with HD had higher risk for MCI (hazard ratio [HR] = 1.29, 95% confidence interval [CI] (1.10, 1.51), P = 0.002; adjusting for sex, years of education). In participants without dementia, those with HD had higher risk for dementia (HR: 1.39, 95% CI, (1.08–1.79), P = 0.011; adjusting sex and education). In individuals with MCI, HD was associated with modestly greater cognitive decline.Conclusions: informant-based HD was associated with increased risk for MCI and dementia.
Unilateral motor progression in MS
Sechi, Elia , Kantarci, Orhun H. , Weinshenker, Brian G. , Weinshenker, Brian G , Sechi, Elia , Keegan, B. Mark , Kaufmann, Timothy J. , Flanagan, Eoin P.

Mayo Clinic

Neurology | July 10, 2019 | Volume: 93 | Issue: 7 | Pages: No page available

10.1212/wnl.0000000000007944 | PMID 31289142 Get It

Identifying asymptomatic infections of visceral leishmaniasis in non-endemic regions with the associated risk factors in Gedaref state, Sudan
Mohamed, Nouh Saad , Ahmed, Ayman, Mohammed, Anwar O., Elaagip, Arwa , Mohamed, Nouh Saad , Osman, Hussam Ali , Muneer, Mohamed S. , Samy, Abdallah M , Siddig, Emmanuel Edwar

Mayo Clinic

No container title available | July 9, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.11134/v1 Get It

Abstract Objectives Visceral Leishmaniasis (VL) can be symptomatic and asymptomatic infection. In this study we aimed at investigating the prevalence of asymptomatic infections and to study risk factors of VL in non-endemic regions in Gedaref state, Sudan. A descriptive cross-sectional study conducted during 2014. Blood samples were collected to serological and molecular analysis. Sticky traps, knockdown spray and CDC miniature light traps were used for the collection of sandflies. Results Ninety-Five participants were included; 52 from Abukishma, 15 Algadamblia Tirfa, 25 Abualnaja and 3 were from Algadamblia Aljabal. Most of the study participants were belonging to the Belala tribe (74.3%). The most frequent reported age was above 40-years old (9.5%). Females were (61.1%) and males were (38.9%). B. aeygptica was the most planted tree in/around the houses (46.3%). 73 (76.8%) of the participants bred more than two types of animals in the house. DAT test revealed 5 positive participants (5.2%). 4/5 DAT positive were past VL infection. PCR detected 35 (36.8%) positive patients. A total of 31 (32.6%) were considered asymptomatic infections based on PCR detection method. Households planted Balanites/Acacia trees or breed domestic animals were found in high percentages with VL PCR positive participants (60.1%, 91.4%).
Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions
Ahmed, Eiman Siddig , Elnour, Lubna S., Chacko, Mintu Elsa, Ali, Eman T. , Munir, Abdalla, Mohamed, Nouh Saad , Mohamed, Nouh Saad , Hassan, Rowa , Siddig, Emmanuel Edwar , Mohamed, Mona A., Muneer, Mohamed S. , Edris, Ali Mahmoud Mohammed

Mayo Clinic

No container title available | July 9, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.11132/v1 Get It

Abstract Objectives: Prostate cancer (PC) is common cancer worldwide. Several markers have been developed to differentiate between benign prostatic hyperplasia (BPH) from PC. A descriptive retrospective hospital-based study aimed at determining the expression of Cyclin D1 in BPH and PC. the study took place at different histopathology laboratories in Khartoum state, Sudan, from December 2016 to January 2019. Formalin-fixed paraffin-embedded blocks were sectioned and fixed in 3-aminopropyltriethoxysilane coated slides incubated into primary antibody for Cyclin D1. The assessment of immunoreactivity of Cyclin D1 of each section was done using the Gleason scoring system. Results: A total of 153 males’ prostate sections included in this study, of them, 120 (78.4%) were PC, and 33 (21.6%) were BPH. Their age ranged from 45 to 88 years, mean age was 66.19 ± 8.599. 142 (92.8%) did not have a family history of PC, while 11 (7.2%) patients reported having a family history. The Gleason scoring showed a total of 81 (52.9%) patients with high-grade and 39 (25.5%) with low-grade. 118 (97.5%) patients had PC showed positive results for Cyclin D1, while BPH was 3 (2.5%). P value < 0.001. Cyclin D1 staining was associated with high-grade Gleason score and perineural invasion, P value 0.001.
Procedure-Related Pain During Image-Guided Percutaneous Biopsies: A Retrospective Study of Prevalence and Predictive Factors
Iyer, Veena R. , Sheedy, Shannon P. , Gunderson, Tina M. , Christopherson, Marie L., Kurup, A. Nicholas , Schmitz, John J. , Atwell, Thomas D. , Kurup, Anil N

Mayo Clinic

American Journal of Roentgenology | July 9, 2019 | Volume: 213 | Issue: 4 | Pages: 755-761

10.2214/ajr.19.21248 | PMID 31287724 Get It

Factors Associated with Cigarette Use During Airmen’s First Year of Service in the United States Air Force
Little, Melissa A. , Ebbert, Jon O. , Krukowski, Rebecca A. , Halbert, Jennifer P. , Kalpinski, Maj Ryan, Talcott, G. Wayne , Klesges, Robert C. , Patten, Christi A.

Mayo Clinic

Military Medicine | July 9, 2019 | Volume: 185 | Issue: 1-2 | Pages: e212-e220

10.1093/milmed/usz155 | PMID 31287888 Get It

Abstract Introduction Despite declines of cigarette use in the civilian population, military personnel report alarmingly high rates of cigarette use. Enlisted Air Force recruits are required to remain tobacco-free for the first 12 weeks of training, and the majority express confidence they will not use tobacco after the ban; however, most previous smokers return to smoking and many nonsmokers initiate. Understanding the factors associated with cigarette-smoking initiation among non-users and re-initiation among former users is critical for the development of successful tobacco control efforts. Materials and Methods The current study examines predictors of cigarette smoking among a sample of 2,188 USAF personnel after their first year of service. Logistic regression analyses examined associations between baseline predictors and initiation and re-initiation of cigarette smoking at a one-year follow-up. Results Compared to never smokers at both time points, the strongest predictor of smoking initiation over the past 12 months was having owned cigarette-branded merchandise (OR 3.81, 95% CI 1.67, 8.71). Compared to former smokers who remained abstinent, the strongest predictor of re-initiation was intention to use tobacco (OR 2.08, 95% CI 1.53, 2.83). Compared to individuals who initiate, the strongest predictors of re-initiation were prior use of other tobacco products and tobacco use intentions (ORs range 1.85 to 4.63). Conclusions Multiple risk factors are associated with tobacco use. Given that Airmen are tobacco-free for the first 12 weeks of training, tobacco interventions during this period might be more effective. Our findings can be used to tailor interventions to prevent tobacco use in the U.S. military.
Double-orifice mitral valve associated and bicuspid aortic valve: forme fruste of Shone's complex?
Foley, Thomas A. , Eidem, Benjamin W., Yang, Li-Tan, Yang, Li‐Tan , Crestanello, Juan A. , Michelena, Héctor I.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | July 9, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ehjci/jez195 | PMID 31302682 Get It